Investor Relations

Here you will find details on our share as well as detailed information on key figures, annual and quarterly results, IR events and much more.

Financial results 2019

HAEMATO AG achieved consolidated sales of 197.8 mEUR (previous year: 274.1 mEUR), an operating result (EBIT) of -19 kEUR (previous year: 6.6 mEUR) and net profit of -1.17 mEUR (previous year: 6.3 mEUR) in the financial year 2019.

After generating consolidated sales of 94.0 mEUR in the first half of 2019, the Group sales in the fourth quarter of 2019 reached 56.0 mEUR. This represents an increase of 17.2% as compared to sales for the third quarter of 2019.

The 2019 net profit will be affected by measurement of financial assets at fair value on the reporting date not affecting liquidity.

Favourable procurement opportunities in the last quarter of 2019 led to a temporary increase in inventories and the associated increase in liabilities. Nevertheless, the HAEMATO Group is well positioned with an equity ratio of 56.2% (previous year: 65.0%) and equity capital of 72.2 mEUR as of December 31, 2019.


Get information about the HAEMATO AG share and get an overview of the current price development.

Rating & Research

Here you will find well-founded stock analyses of renowned research houses and banks on the HAEMATO AG share.

BUY: 6.00 €

GBC AG, 4 September 2019

BUY: 4.80 €

Berlin Equity Research, 9 September 2019

BUY: 6.15 €

Berlin Equity Research, 27 May 2019


Lilienthalstraße 5c
12529 Schönefeld

Phone: +49-30 897 30 86 70
Telefax: +49-30 897 30 86 79